Posts Tagged 'invokana'

New Alerts Over Invokana Amputations

invokana increases risk of amputationsThose who suffer from Type II diabetes are well aware of the risks their disease brings. Medical professionals repeatedly emphasize the importance of keeping up with blood glucose levels, regulating the diet, and exercising. The outcomes of maintaining such vigilance are stark in their contrast. Comply, and you can live a fairly normal life. Fail to comply, however, and the consequences can be tragic.

Amputation; generally of the leg or foot, is among ...

continue reading...

Trouble for Diabetes Drug Makers?

invokana and farxiga mdls to move forwardKnown as SGLT2 inhibitors for short, sodium glucose co-transporter 2 inhibitors are a class of drugs intended for certain individuals with Type II diabetes. The drugs prevent glucose from being absorbed in the kidneys and reduce glucose in the blood by causing it to be expelled in the urine.

Unfortunately, this relatively new class of drugs has already allegedly caused enough harm to warrant FDA action ...

continue reading...

Invokana May Actually Increase Risk of Diabetes Amputations

invokana may increase risk of diabetes-related amputationsThe effects of diabetes on a patient’s body are numerous and wide-ranging. In some cases, the inability to regulate insulin production is the only impact and is resolved in a seemingly simple way. Injection, diet, or an insulin pump that be used to take over sugar regulation for the diabetic. In other cases, however, the patient’s battle is an arduous one and strict compliance with physicians’ instructions is the only ...

continue reading...

Lopez McHugh Files Invokana Lawsuit Alleging Diabetic Ketoacidosis Injury

PHILADELPHIA (December 2015) – The national trial lawyers of Lopez McHugh have filed a lawsuit against Johnson & Johnson and its subsidiary, Janssen, alleging that its diabetes medication, Invokana®, causes patients to develop diabetic ketoacidosis.

The lawsuit (Case No. 15-12-00653) was filed in the Court of Common Pleas, Philadelphia County, and includes allegations that the manufacturers of Invokana knew that the drug could cause diabetic ketoacidosis but failed to warn doctors.

Diabetic ketoacidosis is a condition where the body produces ketones, ...

continue reading...

Woman Claims Invokana Caused Her Diabetic Ketoacidosis

A Georgia woman has filed an Invokana ketoacidosis lawsuit claiming Janssen Pharmaceutical’s drug caused her to develop the potentially life-threatening blood condition known as diabetic ketoacidosis.

Invokana (canagliflozin) is one of a new line of diabetes medications called sodium-glucose cotransport-2 (SLGT2) inhibitors. Unlike traditional insulin treatments, SGLT2 inhibitors regulate the body’s blood sugar levels by reabsorbing excess glucose in the kidneys and disposing of it through urine. Less than two years after Invokana, Farxiga, and Jardiance reached ...

continue reading...

New Study Shows Higher Rate of Diabetic Ketoacidosis with Invokana

diabetic ketoacidosis more prevalent with invokingA new study from the American Diabetes Association journal Diabetes Care found that Type 1 diabetes patients who took Invokana (canagliflozin) alongside insulin therapy were more likely to experience diabetic ketoacidosis. Diabetic ketoacidosis is a severe and potentially fatal blood condition that develops when too many blood acids, or ketones, are present in the body.

Invokana, which is manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals, belongs to a group ...

continue reading...
Page 1 of 3 123